0000000001185692

AUTHOR

Francesca Valentino

showing 50 related works from this author

TRANSCRANIAL DIRECT CURRENT STIMULATION FOR TREATMENT OF FREEZING OF GAIT IN PARKINSON’S DISEASE. A CROSS-OVER STUDY

2013

medicine.medical_specialtyParkinson's diseaseTranscranial direct-current stimulationFreezing of gaitbusiness.industrymedicine.medical_treatmentmedicine.diseaseCrossover studyGait (human)Physical medicine and rehabilitationNeurologymedicineNeurology (clinical)business
researchProduct

Transcranial magnetic stimulation reveals cortical hyperexcitability in episodic cluster headache

2014

Abstract Evidence shows involvement of the cerebral cortex in the pathophysiology of cluster headache (CH). Here we investigated cortical excitability in episodic CH patients by using transcranial magnetic stimulation. In 25 patients with episodic CH and 13 healthy subjects we evaluated the motor cortical response to single-pulse (ie, motor threshold, input-output curves, cortical silent period) and paired-pulse (ie, intracortical facilitation, short intracortical inhibition) transcranial magnetic stimulation in both hemispheres. Thirteen patients were evaluated outside bout and the remaining 12 patients inside bout. Our results showed increased slope of the input-output curves after stimul…

AdultMalemedicine.medical_treatmentStimulationCluster HeadacheFunctional LateralityEpisodic cluster headachemotor cortexMedicineHumanspathophysiologybusiness.industryCluster headacheMedicine (all)cortical excitabilitymedicine.diseaseTranscranial Magnetic StimulationPathophysiologyTranscranial magnetic stimulationmedicine.anatomical_structureAnesthesiology and Pain MedicineNeurologyCerebral cortexTMSepisodic cluster headacheSilent periodFemaleNeurology (clinical)businesshuman activitiesNeuroscienceMotor cortexHuman
researchProduct

Is Transcranial Magnetic Resonance Imaging-Guided Focused Ultrasound a Repeatable Treatment Option? Case Report of a Retreated Patient With Tremor Co…

2019

Introduction In recent years, transcranial Magnetic Resonance Imaging-guided Focused Ultrasound (tcMRgFUS) treatments for functional neurological disorders are giving a new thrust to the field of therapeutic brain lesioning. Objective To present the case of a patient affected by tremor combined with Parkinsonism who underwent a second tcMRgFUS thalamotomy because of relapsing tremor after a few months from the first tcMRgFUS treatment. Methods A 72-yr-old, right-handed man, came to our observation because of a disabling tremor affecting his upper limbs, refusing any invasive surgical procedure and already treated by tcMRgFUS left Vim thalamotomy. However, clinical benefit had brief duration…

Malemedicine.medical_specialtyInterventional magnetic resonance imagingmedicine.medical_treatmentEssential TremorFocused ultrasoundParkinsonian DisordersTremorMedicineHumansAgedmedicine.diagnostic_testbusiness.industryPatient affectedThalamotomySettore MED/27 - NeurochirurgiaParkinsonismSettore FIS/01 - Fisica SperimentaleTreatment optionsSettore MED/37 - NeuroradiologiaMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingTreatment OutcomeStereotaxic techniqueSurgerySettore MED/26 - NeurologiaNeurology (clinical)RadiologyHigh-intensity focused ultrasound ablation Minimally invasive surgical procedures Stereo- taxic techniques Tremor Parkinsonian disorders Interventional magnetic resonance imaging Intraoperative monitoringbusinessSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Intracortical facilitation within the migraine motor cortex depends on the stimulation intensity. A paired-pulse TMS study

2018

Abstract Introduction Connectivity within the primary motor cortex can be measured using the paired-pulse transcranial magnetic stimulation (TMS) paradigm. This evaluates the effect of a first conditioning stimulus on the motor evoked potential (MEP) elicited by a second test stimulus when different interstimulus intervals are used. Aim of the present study was to provide, in patients suffering from migraine without aura (MwoA), additional information on intracortical facilitation (ICF), short intracortical inhibition (SICI), and long intracortical inhibition (LICI), using different intensities of the test stimulus (TS). Methods We enrolled 24 patients with episodic MwoA and 24 age- and sex…

0301 basic medicineAdultMaleMigraine without Auramedicine.medical_specialtyMotor cortex paired pulsemedicine.medical_treatmentRestlcsh:MedicineStimulationAudiologyStimulus (physiology)03 medical and health sciencesYoung Adult0302 clinical medicineHumansMedicineIctalEvoked potentialbusiness.industryElectromyographylcsh:RMotor CortexCortical excitabilityNeural InhibitionGeneral MedicineMiddle Agedmedicine.diseaseEvoked Potentials MotorTranscranial Magnetic StimulationTranscranial magnetic stimulation030104 developmental biologymedicine.anatomical_structureAnesthesiology and Pain MedicineMigraineFemaleNeurology (clinical)Primary motor cortexGlutamatebusiness030217 neurology & neurosurgeryResearch ArticleMotor cortexHuman
researchProduct

A new p65 isoform that bind the glucocorticoid hormone and is expressed in inflammation liver diseases and COVID-19

2021

AbstractInflammation is a physiological process whose deregulation causes some diseases including cancer. Nuclear Factor kB (NF-kB) is a family of ubiquitous and inducible transcription factors, in which the p65/p50 heterodimer is the most abundant complex, that play critical roles mainly in inflammation. Glucocorticoid Receptor (GR) is a ligand-activated transcription factor and acts as an anti-inflammatory agent and immunosuppressant. Thus, NF-kB and GR are physiological antagonists in the inflammation process. Here we show that in mice and humans there is a spliced variant of p65, named p65 iso5, which binds the corticosteroid hormone dexamethasone amplifying the effect of the glucocorti…

MaleCOVID-19.Molecular biologyGene ExpressionDexamethasoneHepatitisMiceGlucocorticoid receptorAdrenal Cortex HormonesProtein IsoformsNF-kBMultidisciplinaryLiver DiseasesQLiver NeoplasmsRNF-kappa BMiddle AgedLiverMedicineFemalemedicine.symptomliver diseaseTranscriptionNFKB P65iso5 inflammationGlucocorticoidmedicine.drugAdultGene isoformCarcinoma HepatocellularScienceImmunologyInflammationBiologyGlucocorticoid ReceptorArticleReceptors GlucocorticoidmedicineAnimalsHumansGlucocorticoidsTranscription factorDexamethasoneInflammationSARS-CoV-2p65 isoformTranscription Factor RelAWild typeCOVID-19Mice Inbred C57BLAlternative SplicingSettore BIO/18 - GeneticaGene Expression RegulationLeukocytes MononuclearCancer researchHormone
researchProduct

Insidious onset of Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease

2014

N.A.

RasagilineN.A.medicine.medical_specialtyNeurologyParkinson's diseasebusiness.industryDermatologyGeneral Medicinemedicine.diseaseInsidious onsetPsychiatry and Mental healthchemistry.chemical_compoundchemistrymedicineNeurology (clinical)NeurosurgerybusinessPsychiatryNeuroradiology
researchProduct

Transcranial direct current stimulation for treatment of freezing of gait: A cross-over study

2014

Background and objective Progression of Parkinson's disease (PD) is frequently characterized by the occurrence of freezing of gait (FOG) representing a disabling motor complication. We aim to investigate safety and efficacy of transcranial direct current stimulation of the primary motor cortex of PD patients with FOG. Methods In this cross-over, double-blind, sham-controlled study, 10 PD patients with FOG persisting in “on” state underwent anodal and sham direct current stimulation for 5 consecutive days. Clinical assessment over a 1-month period was performed. Results A significant improvement of gait, as assessed by the Stand Walk Sit test, with reduction in number and duration of FOG epi…

medicine.medical_specialtyParkinson's diseasegenetic structuresTranscranial direct-current stimulationmedicine.medical_treatmentStimulationmedicine.diseaseGaitPhysical medicine and rehabilitationmedicine.anatomical_structureNeurologyBrain stimulationBasal gangliamedicinePhysical therapyNeurology (clinical)Primary motor cortexPsychologyMotor cortexMovement Disorders
researchProduct

Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke : Posterior ischemic stroke and hemorrhagic transformation.

2017

BACKGROUND: hemorrhagic transformation is a threatening ischemic stroke complication. Frequency of hemorrhagic transformation differs greatly among studies, and its risk factors have been usually studied in patients with anterior ischemic stroke who received thrombolytic therapy. We evaluated, in a hospital-based series of patients with posterior ischemic stroke not treated with thrombolysis, frequency and risk factors of hemorrhagic transformation. Patients with posterior circulation stroke were seen in our Department during the period January 2004 to December 2009. Demographic and clinical information were collected. We estimated risk for spontaneous hemorrhagic transformation by means of…

medicine.medical_specialtymedicine.medical_treatmentCerebral strokeLogistic regressionGeneral Biochemistry Genetics and Molecular BiologyBrain ischemia03 medical and health sciences0302 clinical medicineInternal medicineEpidemiologymedicinebiochemistry030212 general & internal medicineStrokebusiness.industryposterior ischemic strokegenetics and molecular biology (all)epidemiology; hemorrhagic transformation; posterior ischemic stroke; biochemistry genetics and molecular biology (all)General MedicineThrombolysismedicine.diseaseSurgeryhemorrhagic transformationIschemic strokeCardiologyepidemiologyComplicationbusiness030217 neurology & neurosurgery
researchProduct

Cyclical changes of cortical excitability and metaplasticity in migraine: evidence from a repetitive transcranial magnetic stimulation study.

2013

The primary brain dysfunctions leading to the onset of a migraine attack remain largely unknown. Other important open questions concern the mechanisms of initiation, continuation, and termination of migraine pain, and the changes in brain function underlying migraine transformation. Brief trains of high-frequency repetitive transcranial magnetic stimulation (rTMS), when applied to the primary motor cortex at suprathreshold intensity (⩾120% of resting motor threshold [RMT]), elicit in healthy subjects a progressive, glutamate-dependent facilitation of the motor evoked potentials (MEP). Conversely, in conditions of increased cortical excitability, the rTMS trains induce inhibitory MEP respons…

AdultMaleAdolescentHeadache Homeostatic plasticity Magnetic stimulation Migraine pathogenesis Migraine with aura Motor cortexmedicine.medical_treatmentMigraine DisordersYoung AdultChronic MigrainemedicineHumansIctalAgedNeuronal PlasticityElectromyographyMotor CortexMiddle Agedmedicine.diseaseTranscranial Magnetic StimulationMigraine with auraTranscranial magnetic stimulationAnesthesiology and Pain Medicinemedicine.anatomical_structureNeurologyMigraineCortical spreading depressionFemaleNeurology (clinical)Primary motor cortexmedicine.symptomPsychologyNeuroscienceMotor cortexPainReferences
researchProduct

In patient’s with Parkinson disease, autonomic symptoms are frequent and associated with other non-motor symptoms

2015

Background: Autonomic symptoms and sleep disorders are common non-motor symptoms of Parkinson disease (PD), which are correlated with poor quality of life for patients. Purpose: To assess the frequency of autonomic symptoms in a consecutive series of PD patients and to correlate them with other motor and non-motor symptoms. Methods: All consecutive non-demented PD patients who underwent an extensive evaluation including Hoehn and Yahr staging, Unified Parkinson’s Disease Rating Scale, Beck’s Depression Inventory, Neuropsychiatric Inventory, PDQ-39 Scale, the Parkinson’s diseases Sleep Scale, the Epworth Sleepiness Scale and SCOPA-AUT scale were enrolled. Comorbidity has been also considered…

Malemedicine.medical_specialtyLevodopaNeurologyParkinson's diseaseDiseaseAutonomic symptomNon-motor symptomRating scaleInternal medicinemedicineHumansDepression (differential diagnoses)AgedEndocrine and Autonomic Systemsbusiness.industryEpworth Sleepiness ScaleParkinson DiseaseSleep disordersMiddle Agedmedicine.diseaseComorbidityCross-Sectional StudiesAutonomic Nervous System DiseasesParkinson’s diseaseFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessmedicine.drug
researchProduct

Expression and developmental regulation of the cystine/glutamate exchanger (xc-) in the rat.

2007

The cystine/glutamate exchanger (antiporter x c − ) is a membrane transporter involved in the uptake of cystine, the rate-limiting amino acid in the synthesis of glutathione. Recent studies suggest that the antiporter plays a role in the slow oxidative excitotoxity and in the pathological effects of β-N-oxalylamino-l-alanine, the molecule responsible for neurolathyrism, a neurotoxic upper motor neuron disease. The mouse cystine/glutamate exchanger has been cloned and showed to be composed of two distinct proteins, one of which being a novel protein, named xCT, of 502 amino acids and 12 putative trans-membrane domains. We have generated and purified a polyclonal antibody to mouse xCT and stu…

MaleAmino Acid Transport SystemsAntiporterProtein subunitBlotting WesternImmunoblottingCystineGlutamic AcidBiologyBiochemistryRats Sprague-DawleyCellular and Molecular Neurosciencechemistry.chemical_compoundMiceWestern blotChlorocebus aethiopsmedicineAnimalsHumansCystine/glutamate exchanger Protein expression Cell cultures Developmenchemistry.chemical_classificationCerebral CortexNeuronsmedicine.diagnostic_testGlutamate receptorGene Expression Regulation DevelopmentalGeneral MedicineGlutathioneFibroblastsImmunohistochemistryAmino acidRatsBiochemistrychemistryAstrocytesCOS CellsCystineSettore MED/26 - NeurologiaElectrophoresis Polyacrylamide GelCell fractionationSubcellular FractionsNeurochemical research
researchProduct

Reversible Pisa Syndrome in a patient with Parkinson's disease on rasagiline therapy

2013

RasagilinePediatricsmedicine.medical_specialtyParkinson's diseasebusiness.industrymedicine.diseasechemistry.chemical_compoundNeurologychemistryPhysical therapyMedicineNeurology (clinical)businessPisa Syndrome rasagilineJournal of the Neurological Sciences
researchProduct

TRANSCRANIAL DIRECT CURRENT STIMULATION ENHANCES SUCKING OF A LIQUID BOLUS IN HEALTHY HUMANS

2014

Abstract Background Transcranial direct current stimulation (tDCS) is a non-invasive technique used for modulating cortical excitability in vivo in humans. Here we evaluated the effect of tDCS on behavioral and electrophysiological aspects of physiological sucking and swallowing. Methods Twelve healthy subjects underwent three tDCS sessions (anodal, cathodal and sham stimulation) on separate days in a double-blind randomized order. The active electrode was placed over the right swallowing motor cortex. Repeated sucking and swallowing acts were performed at baseline and at 15 and 60 min after each tDCS session and the mean liquid bolus volume ingested at each time point was measured. We also…

AdultMalemedicine.medical_treatmentBiophysicsElectromyographySuctionTranscranial Direct Current StimulationtDCSlcsh:RC321-571Young AdultDouble-Blind MethodSwallowingstomatognathic systemmedicineHumansMuscle Skeletallcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBrain stimulation; Dysphagia; Electromyography; Suction; Swallowing; tDCSAgedmedicine.diagnostic_testTranscranial direct-current stimulationElectromyographyGeneral NeuroscienceMotor CortexDysphagiaMiddle AgedSwallowingDysphagiaHealthy VolunteersDeglutitionElectrophysiologymedicine.anatomical_structureBrain stimulationSucking BehaviorAnesthesiaBrain stimulationPharynxFemaleSettore MED/26 - NeurologiaNeurology (clinical)Larynxmedicine.symptomBolus (digestion)Deglutition DisordersPsychologyMotor cortex
researchProduct

Positive ice pack test in a case of food-borne botulism: a clinical note

2012

business.industrymedicine.medical_treatmentmedicine.diseaseTest (assessment)NeurologyBotulism ice pack testFood borneEnvironmental healthmedicineIce packSettore MED/26 - NeurologiaBotulismNeurology (clinical)businessJournal of Neurology
researchProduct

Urological dysfunctions in patients with Parkinson’s disease: clues from clinical and non-invasive urological assessment

2018

Abstract Background Autonomic nervous system dysfunction, common in patients with Parkinson’s disease (PD), causes significant morbidity and it is correlated with poor quality of life. To assess frequency of urinary symptoms in patients with PD, without conditions known to interfere with urinary function. Methods Non-demented PD patients were consecutively enrolled from the outpatients clinic of our department. Scales investigating motor and non-motor symptoms were carried out. Evaluation of urinary dysfunctions was carried out using the AUTonomic Scale for Outcomes in Parkinson’s disease (SCOPA-AUT) questionnaire. Patients underwent noninvasive urological studies (nUS), including uroflowme…

AdultMaleUrologic Diseasesmedicine.medical_specialtyNeurologyParkinson's diseaseUrinary systemAutonomic dysfunction030232 urology & nephrologyNon-motor symptomsUrinary symptomsDiseaseNon-motor symptomlcsh:RC346-429SCOPA-AUT03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesInternal medicinemedicineHumansNeurochemistryStage (cooking)lcsh:Neurology. Diseases of the nervous systemAgedbusiness.industryAUTonomic SCale for outcomes in Parkinson’s diseaseParkinson DiseaseGeneral MedicineMiddle AgedUrinary functionmedicine.diseaseAutonomic Nervous System DiseasesQuality of LifeParkinson’s diseaseFemaleSettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusiness030217 neurology & neurosurgeryBMC Neurology
researchProduct

Pisa syndrome after rasagiline therapy in a patient with Parkinson’s disease

2015

Dear Editor, We have read with interest comments by Solla et al. [1] regarding our Letter to the Editor published in NeurologicalSciences titled ‘‘Insidious onset of Pisa Syndrome afterrasagiline therapy in a patient with Parkinson’s Disease’’[2]. We thank the authors for their interest in our paper, but we think it is necessary to make some clarifications regarding the temporal relationship between the onset of Pisa Syndrome (PS) and rasagiline therapy. PS occurred in fact after and not before rasagiline treatment as stated by Solla et al. In particular, PS occurred after a time interval of 6–12 months and anyway after rasagiline was added to patient’s therapy. This long time interval is o…

Pediatricsmedicine.medical_specialtyParkinson's diseaseNeurologyParkinson's diseaseDermatologyAntiparkinson Agentschemistry.chemical_compoundDopaminemedicineHumansMonoamine Oxidase Type BDystoniaRasagilineAntiparkinsonian drugsbusiness.industryParkinson DiseaseGeneral Medicinemedicine.diseasePsychiatry and Mental healthDystoniaPisa syndromechemistryAntiparkinson AgentsIndansFemaleNeurology (clinical)businessmedicine.drug
researchProduct

Elevated cerebrospinal fluid and plasma homocysteine levels in ALS

2009

Background:  High cerebrospinal fluid (CSF) and plasma levels of homocysteine (HC) have been reported in certain neurodegenerative disorders, such as Alzheimer’s, Parkinson’s diseases and, recently, amyotrophic lateral sclerosis (ALS). Objectives:  To assay the CSF and plasma levels of HC in ALS patients and controls, and to evaluate the relationship between HC levels and clinical variables of the disease. Methods:  Cerebrospinal fluid from sixty-nine (M/F 1.87) and plasma from sixty-five ALS patients (M/F 1.83) were taken and stored at −80°C until use. Controls (CSF = 55; plasma = 67) were patients admitted to our hospital for neurological disorders with no known relationship to HC changes…

Pathologymedicine.medical_specialtyHomocysteinebusiness.industryDisease progressionPlasma levelsmedicine.diseaseGastroenterologyPathophysiologychemistry.chemical_compoundCerebrospinal fluidNeurologychemistryInternal medicinePredictive value of testsmedicinePlasma homocysteineNeurology (clinical)Amyotrophic lateral sclerosisbusinessEuropean Journal of Neurology
researchProduct

The importance of the reproducibility of oropharyngeal swallowing in amyotrophic lateral sclerosis. An electrophysiological study

2017

Abstract Objective To investigate electrophysiologically the reproducibility of oropharyngeal swallowing in patients with ALS. Methods We enrolled 26 ALS patients, both with and without clinical signs of dysphagia, and 30 age-matched controls. The reproducibility of the electrophysiological signals related to the oral phase (electromyographic activity of the submental/suprahyoid muscles) and the pharyngeal phase (laryngeal-pharyngeal mechanogram) of swallowing across repeated swallows was assessed. To do this we computed two similarity indexes (SI) by using previously described mathematical algorithms. Results The reproducibility of oropharyngeal swallowing was significantly reduced both in…

MaleNeurologyElectromyographyAudiology0302 clinical medicineAmyotrophic lateral sclerosisDeglutition Disorder030223 otorhinolaryngologySimilarity indexmedicine.diagnostic_testdigestive oral and skin physiologyDysphagiaMiddle AgedDysphagiaSensory Systemsmedicine.anatomical_structureNeurologyAnesthesiaSuprahyoid musclesFemalemedicine.symptomCase-Control StudieHumanAdultmedicine.medical_specialtyReproducibility of Result03 medical and health sciencesstomatognathic systemSwallowingALS; Deglutition; Dysphagia; Electrophysiological evaluation of swallowing; Motor neuron disease; Similarity index; Adult; Aged; Amyotrophic Lateral Sclerosis; Case-Control Studies; Deglutition Disorders; Electromyography; Female; Humans; Male; Middle Aged; Pharynx; Reproducibility of Results; Deglutition; Sensory Systems; Neurology; Neurology (clinical); Physiology (medical)Physiology (medical)otorhinolaryngologic diseasesmedicineHumansMotor neuron diseaseAgedbusiness.industryElectromyographyPharynxAmyotrophic Lateral SclerosisReproducibility of Resultsmedicine.diseaseElectrophysiological evaluation of swallowingDeglutitionCase-Control StudiesPharynxNeurology (clinical)ALSbusinessSensory SystemDeglutition Disorders030217 neurology & neurosurgeryOropharyngeal dysphagiaAmyotrophic Lateral Sclerosi
researchProduct

Preliminary experience with a transcranial magnetic resonance-guided focused ultrasound surgery system integrated with a 1.5-T MRI unit in a series o…

2018

OBJECTIVETranscranial magnetic resonance–guided focused ultrasound surgery (tcMRgFUS) is one of the emerging noninvasive technologies for the treatment of neurological disorders such as essential tremor (ET), idiopathic asymmetrical tremor-dominant Parkinson’s disease (PD), and neuropathic pain. In this clinical series the authors present the preliminary results achieved with the world’s first tcMRgFUS system integrated with a 1.5-T MRI unit.METHODSThe authors describe the results of tcMRgFUS in a sample of patients with ET and with PD who underwent the procedure during the period from January 2015 to September 2017. A monolateral ventralis intermedius nucleus (VIM) thalamic ablation was pe…

MaleParkinson's diseaseMovement disordershigh-intensity focused ultrasound ablationIntraoperative Neurophysiological Monitoringmedicine.medical_treatmentinterventional030218 nuclear medicine & medical imagingMagnetic resonance guided focused ultrasound surgery0302 clinical medicineThalamusEssential tremorSettore MED/27 - NeurochirurgiaUltrasoundSettore MED/37 - NeuroradiologiaParkinson DiseaseGeneral MedicineMiddle AgedAblationMagnetic Resonance ImagingTreatment OutcomeNeuropathic painBBB = blood-brain barrier; ET = essential tremor; FRFSE = fast recalled FSE; FSE = fast spin echo; FSPGR = fast spoiled gradient echo; FTM = Fahn-Tolosa-Marin; HI-FU = high-intensity focused ultrasound; MRI; MRgFUS; MS = multiple sclerosis; PD = Parkinson’s disease; Parkinson’s disease; QUEST = Quality of Life in Essential Tremor; SWAN = susceptibility-weighted angiography; UPDRS = Unified Parkinson’s Disease Rating Scale; VIM = ventralis intermedius nucleus; brain; essential tremor; high-intensity focused ultrasound ablation; interventional; magnetic resonance–guided focused ultrasound surgery; stereotactic technique; tcMRgFUS = transcranial magnetic resonance–guided focused ultrasound surgerySettore MED/26 - NeurologiaFemaleRadiologymedicine.symptombrain; essential tremor; high-intensity focused ultrasound ablation; interventional; magnetic resonance-guided focused ultrasound surgery; mrgfus; mri; parkinson's disease; stereotactic techniqueMRIAdultmedicine.medical_specialtybrainEssential Tremormagnetic resonance–guided focused ultrasound surgery03 medical and health sciencesmedicineHumansmagnetic resonance-guided focused ultrasound surgeryUltrasonography InterventionalAgedThalamotomybusiness.industryMRgFUSmedicine.diseasestereotactic techniqueparkinson's diseaseParkinson’s diseaseSurgeryNeurology (clinical)businessSettore MED/36 - Diagnostica Per Immagini E Radioterapia030217 neurology & neurosurgeryFollow-Up StudiesNeurosurgical focus
researchProduct

A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis

2009

The cause of sporadic amyotrophic lateral sclerosis (ALS) is largely unknown, but genetic factors are thought to play a significant role in determining susceptibility to motor neuron degeneration. To identify genetic variants altering risk of ALS, we undertook a two-stage genome-wide association study (GWAS): we followed our initial GWAS of 545 066 SNPs in 553 individuals with ALS and 2338 controls by testing the 7600 most associated SNPs from the first stage in three independent cohorts consisting of 2160 cases and 3008 controls. None of the SNPs selected for replication exceeded the Bonferroni threshold for significance. The two most significantly associated SNPs, rs2708909 and rs2708851 …

amyotrophic lateral sclerosisLinkage disequilibriumPopulationamyotrophic lateral sclerosis; genetics; GWASingle-nucleotide polymorphismGenome-wide association studyBiologyGWAPolymorphism Single Nucleotide03 medical and health sciences0302 clinical medicineGenotypeGeneticsmedicineHumansPolymorphismAmyotrophic lateral sclerosiseducationMolecular BiologyGenetics (clinical)030304 developmental biologyGenetics0303 health scienceseducation.field_of_studyGenomeSLA wide genome screeningGenome HumanAssociation Studies ArticlesCase-control studySingle NucleotideGeneral MedicineOdds ratiomedicine.diseaseSettore MED/26 - NEUROLOGIAAmyotrophic Lateral Sclerosis; genetics Case-Control Studies Genome; Human Genome-Wide Association Study Humans Polymorphism; Single NucleotideCase-Control Studies030217 neurology & neurosurgeryHumanGenome-Wide Association StudyHuman Molecular Genetics
researchProduct

Cerebrospinal fluid tau protein is not a biological marker in amyotrophic lateral sclerosis.

2009

Background:  Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder leading to progressive motor neuron cell death. Etiopathogenesis is still imperfectly known and much effort have been undertaken to find a biological marker that could help in the early diagnosis and in the monitoring of disease progression. Cerebrospinal fluid (CSF) concentrations of tau, an axonal microtubule-associated protein, have been measured in ALS with levels found increased in some studies and unchanged in others. Methods:  Total CSF tau level was assayed in a population of ALS patients (n = 57) and controls (n = 110) using a specific ELISA method. Results:  No significant differences in the median CS…

MaleProgrammed cell deathPathologymedicine.medical_specialtyTau proteinPopulationEnzyme-Linked Immunosorbent Assaytau Proteinscerebrospinal fluidtau proteinCerebrospinal fluiddisease progressionHumansMedicineamyotrophic lateral sclerosiAmyotrophic lateral sclerosisElisa methodeducationAgededucation.field_of_studybiologybusiness.industryAmyotrophic Lateral SclerosisDisease progressionMiddle AgedMotor neuronmedicine.diseasemedicine.anatomical_structureNeurologybiology.proteinamyotrophic lateral sclerosis cerebrospinal fluid disease progression tau proteinFemaleSettore MED/26 - NeurologiaNeurology (clinical)businessBiomarkers
researchProduct

Is trans-cranial MR-guided Focused UltraSound a repeatable treatment option? Report of a successfully re-treated patient

2018

Background: In recent years, transcranial Magnetic Resonance-guided Focused UltraSounds (tcMRgFUS) treatments for functional neurological disorders are giving a new thrust to the field of therapeutic brain lesioning. This technique has been proven safe and effective in selected patients. Here we present the case of a patient affected by tremor combined with parkinsonism who underwent a second tcMRgFUS thalamotomy because of relapsing tremor after a few months from the first tcMRgFUS treatment. Materials and Methods: A 72-year-old, right-handed man, who came to our observation because of a disabling tremor affecting mainly his upper right limb and refusing any invasive surgical procedure. Hi…

Settore MED/27 - Neurochirurgiatranscranial Magnetic Resonance-guided Focused UltraSounds (tcMRgFUS) ParkinsonSettore MED/37 - NeuroradiologiaSettore MED/26 - NeurologiaSettore MED/36 - Diagnostica Per Immagini E Radioterapia
researchProduct

Effects of More-Affected vs. Less-Affected Motor Cortex tDCS in Parkinson’s Disease

2017

Objective. To evaluate therapeutic potential of different montages of transcranial direct current stimulation (tDCS) in Parkinson’s Disease (PD) patients with asymmetric motor symptoms. Materials and Methods. Fourteen patients with asymmetric PD underwent, while on treatment, seven separate sessions including electrophysiological and clinical evaluation at baseline and after anodal, cathodal and sham tDCS of the primary motor cortex (M1) of the two hemispheres. Changes in motor cortical excitability were evaluated by transcranial magnetic stimulation. Effects on motor symptoms were assessed by testing finger tapping and upper limb bradykinesia, and by using the Italian validated Movement Di…

0301 basic medicinemedicine.medical_specialtynon-invasive brain stimulationParkinson's diseaseNeurologymedicine.medical_treatmenttDCSlcsh:RC321-57103 medical and health sciencesBehavioral Neuroscience0302 clinical medicinePhysical medicine and rehabilitationmotor cortexmedicineParkinsonâ s diseaselcsh:Neurosciences. Biological psychiatry. NeuropsychiatryBiological PsychiatryOriginal ResearchTranscranial direct-current stimulationcortical excitabilitymedicine.diseaseTranscranial magnetic stimulationElectrophysiology030104 developmental biologymedicine.anatomical_structureNeuropsychology and Physiological PsychologyNeurologyPsychiatry and Mental HealthFinger tappingParkinson’s diseaseSettore MED/26 - NeurologiaPrimary motor cortexPsychologyNeuroscience030217 neurology & neurosurgeryMotor cortexCortical excitability; Motor cortex; Non-invasive brain stimulation; Parkinson’s disease; tDCS; Neuropsychology and Physiological Psychology; Neurology; Psychiatry and Mental Health; Biological Psychiatry; Behavioral NeuroscienceNeuroscienceFrontiers in Human Neuroscience
researchProduct

A cervical myelopathy with a Hirayama disease-like phenotype

2008

A 21-year-old man with a muscular atrophy of the left distal upper extremity is presented. The disorder had been progressive over a few years, showing an exacerbation of the hand's weakness when the patient worked in a chilled environment (i.e., in a cold room). The patient's diagnostic work-up was extensive and the MRI documented the presence of a cervical myelopathy, associated to an inversion of the physiological lordosis at the C5-C6 level, with a phenotype highly resembling Hirayama disease. This case indirectly supports the debated hypothesis that juvenile amyotrophy of the upper limb (Hirayama disease) is actually a type of cervical myelopathy, with a likely ischaemic pathogenesis of…

Malemedicine.medical_specialtyWeaknessHIRAYAMANeurologyCumulative Trauma DisordersDermatologyFunctional LateralityMuscular Atrophy SpinalYoung AdultMyelopathyAtrophyIschemiaSpinal cord compressionNeural PathwaysmedicineHumansKyphosisMuscle SkeletalCervical myelopathy Hirayama disease Muscular atrophy MRIMuscle Weaknessbusiness.industryMuscle weaknessSyndromeGeneral MedicineAnatomyAmyotrophymedicine.diseaseMagnetic Resonance ImagingCold TemperatureOccupational DiseasesPsychiatry and Mental healthmedicine.anatomical_structureSpinal CordArmCervical VertebraeDisease ProgressionUpper limbSettore MED/26 - NeurologiaNeurology (clinical)medicine.symptombusinessSpinal Cord CompressionNeurological Sciences
researchProduct

Frequency and determinants for hemorrhagic transformation of posterior cerebral stroke

2017

Abstract Background hemorrhagic transformation is a threatening ischemic stroke complication. Frequency of hemorrhagic transformation differs greatly among studies, and its risk factors have been usually studied in patients with anterior ischemic stroke who received thrombolytic therapy. We evaluated, in a hospital-based series of patients with posterior ischemic stroke not treated with thrombolysis, frequency and risk factors of hemorrhagic transformation. Patients with posterior circulation stroke were seen in our Department during the period January 2004 to December 2009. Demographic and clinical information were collected. We estimated risk for spontaneous hemorrhagic transformation by …

Aged 80 and overMaleHemorrhagic transformationEpidemiologylcsh:Rlcsh:MedicineBrain IschemiaStrokelcsh:Biology (General)Posterior ischemic strokeRisk FactorsHumansFemalelcsh:Science (General)lcsh:QH301-705.5lcsh:Q1-390Research ArticleAgedCerebral HemorrhageBMC Research Notes
researchProduct

Early and late mortality of spontaneous hemorrhagic transformation of ischemic stroke.

2014

Background Hemorrhagic transformation (HT), a complication of ischemic stroke (IS), might influence patient's prognosis. Our aim is to evaluate, in a hospital-based series of patients not treated with thrombolysis, the relationship between HT and mortality. Methods We compared mortality of individuals with spontaneous HT with that of individuals without. Medical records of patients diagnosed with anterior IS were retrospectively reviewed. Outcome measures were 30- and 90-day survival after IS onset. Kaplan–Meier estimates were used to construct survival curves. Cox proportional hazards model was used to estimate hazard ratio (HR) for the main outcome measure (death). HT was stratified in he…

Malemedicine.medical_specialtysurvivalBrain IschemiaCohort StudiesHematomaRisk FactorsInternal medicineMedicineHumansStrokeSurvival analysisAgedRetrospective StudiesAged 80 and overIschemic strokeAspirinbusiness.industryProportional hazards modelHeparinMortality rateRehabilitationHazard ratioAnticoagulantsIschemic stroke; epidemiology; hemorrhagic transformation; prognosis; survivalMiddle Agedmedicine.diseaseConfidence intervalSurgeryStrokeSurvival Ratehemorrhagic transformationCardiologyDisease ProgressionepidemiologySettore MED/26 - NeurologiaSurgeryFemaleNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessComplicationIntracranial HemorrhagesprognosiPlatelet Aggregation InhibitorsFollow-Up StudiesJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
researchProduct

COGNITIVE IMPAIRMENT IN PATIENTS WITH PARKINSON’S DISEASE

2011

Settore MED/26 - NeurologiaCOGNITIVE IMPAIRMENTPARKINSON’S DISEASE
researchProduct

THE PALMOMENTAL REFLEX IN AMYOTROPHIC LATERA SCLEROSIS

2007

Settore MED/26 - NeurologiaTHE PALMOMENTAL REFLEX AMYOTROPHIC LATERA SCLEROSIS
researchProduct

Sleep disturbances and dysautonomic dysfunction are associated in patients with Parkinson’s disease

2012

Parkinson's disease dysautonomic dysfunction sleep disturbancesSettore MED/26 - Neurologia
researchProduct

EFFECT OF A MULTIDISCIPLINARY ALS CLINIC ON NIV TOLERANCE AND SURVIVAL IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS AND BULBAR IMPAIRMENT: A PROSPE…

2009

...

NIV ALSSettore MED/26 - Neurologia
researchProduct

DIABETIC THORACIC POLYRADICULOPATHY: A CASE WITH CLINICAL IMPROVEMENT FROM INTRAVENOUS IMMUNOGLOBULIN.

2008

...

Settore MED/26 - NeurologiaDIABETIC THORACIC POLYRADICULOPATHYDiabetic thoracic polyradicolopathy - iv immuniglobulin
researchProduct

URIC ACID LEVELS IN SERUM AND CSF OF ALS PATIENTS

2009

Objective: Urate (UA) is a potent antioxidant that effectively scavenges reactive nitrogen and oxygen radicals, and persons with a high plasma UA level may be at lower risk of some neurodegenerative disorders, as Parkinson’s disease (PD). Low plasma UA level has been observed in Alzheimer’s disease (AD) and vascular dementia, but there is no data on correlations to neuropsychological test results in these patient groups. Amyotrophic Lateral Sclerosis (ALS) is a devastating motor neuron disease, with a highly variable rate of progression and whose diagnosis is chiefly based on clinical and neurophysiological parameters. The etiopathogenesis is unknown, but the oxidative stress seems to play …

Settore MED/26 - NeurologiaURIC ACID ALS
researchProduct

ANODAL TRANSCRANIAL DIRECT CURRENT STIMULATION (TDCS) APPLIED TO THE MOTOR CORTEX AMELIORATES FREEZING OF GAIT IN PATIENTS AFFECTED BY PARKINSON’S DI…

2012

Background: Progression of Parkinson’s disease (PD) is frequently characterized by the occurrence of freezing of gait (FOG), which generally does not improve with dopaminergic therapy and with current available surgical therapies. Recent evidences show that motor symptoms may be ameliorated by means of non-invasive brain stimulation techiniques in PD (transcranial current direct stimulation, TDCS; repetitive transcranial magnetic stimulation, RTMS). Objective: To investigate the efficacy of anodal TDCS in the treatment of FOG in PD. Excitatory anodal tDCS was applied unilaterally to the motor and premotor cortices controlateral to the most affected leg. Methods: randomized, double-blind, sh…

Settore MED/26 - NeurologiaFreezing of gait Parkinsons'disease
researchProduct

“Caratterizzazione funzionale di p65(-1), nuova isoforma di p65 del complesso NF-kB e preparazione di un clone per l'ingegnerizzazione di un topo p65…

2014

NF-kB è un fattore di trascrizione eucariotico e ubiquitario che regola l’espressione di geni coinvolti in molteplici processi cellulari come la risposta immunitaria, la flogosi, l’apoptosi, la crescita cellulare e lo sviluppo embrionale. Le proteine appartenenti alla famiglia di NF-kB sono p65, c-Rel, RelB, p50 e p52. Tali proteine svolgono la funzione di fattori trascrizionali legando specifiche consensus del DNA (consensus kB) sotto forma di omo - eterodimeri. Ogni membro della famiglia di NF-kB è caratterizzato dalla presenza di un dominio, altamente conservato, il “Rel Homology Domain” (RHD). Nel RHD sono stati mappati i sottodomini di dimerizzazione, interazione con gli inibitori (IkB…

isoformaSettore BIO/11 - Biologia Molecolare
researchProduct

IMMUNOSUPPRESSANT TREATMENT AND CANCER RISK IN A COHORT OF PATIENTS AFFECTED BY MULTIPLE SCLEROSIS

2011

CANCER RISKSettore MED/26 - NeurologiaMULTIPLE SCLEROSIS
researchProduct

EXPRESSION OF THE CYSTINE/GLUTAMATE EXCHANGER IN THE RAT BRAIN

2005

researchProduct

LATE MORTALITY OF HEMORRHAGIC TRANSFORMATION OF ISCHEMIC STROKE

2012

Introduction. Hemorrhagic transformation (HT), a complication of ischemic stroke (IS) is supposed to influence patient’s prognosis. Aim of our study was to evaluate, in a hospital-based series of patients not treated with thrombolysis, the relationship between HT and late mortality. Methods. Mortality of individuals with spontaneous HT was compared to that of individuals without. Medical records of patients diagnosed with anterior IS during the period 2004-2006 were reviewed. Living status was obtained from the public record office of the municipality of Palermo or indirectly by telephone interview. Outcome measure was 90 days survival after IS onset. Kaplan-Meier estimates were used to con…

Hemorrhagic transformation mortalitySettore MED/26 - Neurologia
researchProduct

CLINICAL EFFECTS OF DIFFERENT MONTAGES OF TRANSCRANIAL DIRECT CURRENT STIMULATION IN PATIENTS WITH PARKINSON’DISEASE

2014

tDCS Parkinson Disease
researchProduct

ESPRESSIONE DELL’ANTIPORTER CISTINA/GLUTAMMATO XC- NEL SISTEMA NERVOSO DI RATTO

2007

Settore MED/26 - NeurologiaAntiporter malattie neurodegenerative
researchProduct

IDENTIFICATION OF A NOVEL COMPOUND HETEROZYGOUS MUTATION OF SPG11 IN A PATIENT AFFECTED BY HSPWITH THIN CORPUS CALLOSUM

2010

SPG11CORPUS CALLOSUMSettore MED/26 - Neurologia
researchProduct

DYSAUTONOMIC DYSFUNCTION IN PARKINSON’DISEASE BY SCOPA-AUT SCALE

2012

...

Settore MED/26 - NeurologiaDYSAUTONOMIC DYSFUNCTION PARKINSON’DISEASE SCOPA-AUT SCALE
researchProduct

PARKINSON’S DISEASE AND PARKINSON’S DISEASE FAMILIAL HISTORY. RESULTS OF A CASE-CONTROL STUDY

2011

PARKINSON’S DISEASE FAMILIAL HISTORYSettore MED/26 - Neurologia
researchProduct

Frequency of cognitive impairment and factors associated in outpatients with Parkinson’s disease

2011

cognitive impairment Parkinson diseaseSettore MED/26 - Neurologia
researchProduct

LEPROSY: A CASE REPORT FROM SICILY, ITALY

2009

...

LEPROSYSettore MED/26 - Neurologia
researchProduct

RISK FACTORS FOR DYSKINESIAS IN PATIENTS WITH PARKINSON'S DISEASE

2011

DYSKINESIASSettore MED/26 - NeurologiaPARKINSON'S DISEASE
researchProduct

Repeated courses of granulocyte colony-stimulating factor in amyotrophic lateral sclerosis: clinical and biological results from a prospective multic…

2011

Granulocyte colony-stimulating factor (G-CSF) induces a transient mobilization of hematopoietic progenitor cells from bone marrow to peripheral blood. Our aim was to evaluate safety of repeated courses of G-CSF in patients with amyotrophic lateral sclerosis (ALS), assessing disease progression and changes in chemokine and cytokine levels in serum and cerebrospinal fluid (CSF). Twenty-four ALS patients entered an open-label, multicenter trial in which four courses of G-CSF and mannitol were administered at 3-month intervals. Levels of G-CSF were increased after treatment in the serum and CSF. Few and transitory adverse events were observed. No significant reduction of the mean monthly decrea…

Keywords:amyotrophic lateral sclerosiclinical trialhematopoietic stem cellSettore MED/26 - Neurologiagranulocyte colony-stimulating factorneuroinflammation
researchProduct

DYSAUTOMIC DISFUNCTON OCCURS EARLY IN PARKINSON DISEASE

2011

Settore MED/26 - NeurologiaDYSAUTOMIC DISFUNCTONPARKINSON DISEASE
researchProduct

CSF HOMOCYSTEINE LEVELS IN AMYOTROPHC LATERAL SCLEROSIS

2008

CSF HOMOCYSTEINEA MYOTROPHC LATERAL SCLEROSISSettore MED/26 - Neurologia
researchProduct

CSF homocysteine levels in Amyotrophic Lateral Sclerosis

2008

CSF ALS
researchProduct

SERUM CREATINE KINASE LEVEL IN AMYOTROPHIC LATERAL SCLEROSIS: A USEFUL DIAGNOSTIC AID?

2008

...

CK - ALSSettore MED/26 - NeurologiaSERUM CREATINE KINASE AMYOTROPHIC LATERAL SCLEROSIS
researchProduct